By the time a patient with heart failure notices worsening shortness of breath or swollen legs, changes inside the cardiovascular system may have already been developing for days. New remote-monitoring technologies are giving heart failure teams an opportunity to detect some of those changes earlier.
Key Takeaways
Worsening heart failure is often preceded by increasing pressure inside the heart and pulmonary circulation before obvious symptoms of congestion appear.
Traditional warning signs such as weight gain, swelling, fatigue, and shortness of breath remain important, but they may occur relatively late in the deterioration process.
Implantable pulmonary artery pressure sensors can allow selected patients to transmit daily pressure readings from home.
In February 2026, NICE recommended CardioMEMS as an option for selected adults with NYHA class III chronic heart failure who are at risk of hospitalization.
Remote monitoring is not simply about collecting data. Nurses play a major role in reviewing trends, contacting patients, assessing symptoms, reinforcing self-care, and coordinating medication changes or escalation of care.
Technology may help clinicians recognize deterioration earlier, but it does not replace clinical assessment.
For many people living with heart failure, worsening symptoms seem to arrive suddenly.
One day, walking around the house feels manageable.
A few days later, climbing a few steps causes breathlessness.
Shoes feel tighter.
The legs begin to swell.
Sleeping flat becomes uncomfortable.
Body weight has increased.
Eventually, the patient may arrive at an emergency department with significant congestion.
But inside the body, that deterioration may not have started on the day symptoms became obvious.
Changes in cardiovascular pressures can occur days or even weeks earlier.
That has created an important opportunity in heart failure care:
What if healthcare professionals could recognize worsening heart failure before the patient feels seriously unwell?
Remote monitoring is beginning to make that possible for some patients.
Why Does Heart Failure Get Worse?
Heart failure occurs when the heart cannot pump or fill effectively enough to meet the body's needs.
When the condition becomes unstable, pressure can build inside the cardiovascular system.
Fluid may begin accumulating.
Eventually, patients may develop familiar symptoms such as:
shortness of breath,
difficulty breathing when lying flat,
waking at night feeling breathless,
swelling in the feet or legs,
rapid weight gain,
fatigue,
reduced exercise tolerance,
abdominal fullness, or
worsening cough.
These symptoms can indicate congestion, one of the major reasons patients with heart failure require hospitalization.
But congestion does not necessarily begin when swelling becomes visible.
Hemodynamic changes may develop first.
The Heart Failure Association of the European Society of Cardiology explains that increasing intracardiac and pulmonary artery pressures can precede obvious clinical congestion by several days or even weeks. (pubmed.ncbi.nlm.nih.gov)
In other words:
The patient may feel relatively well while the heart is already beginning to struggle.
Why Isn't Daily Weight Enough?
Patients with heart failure are commonly taught to monitor their weight.
There is a good reason for this.
Rapid weight gain can suggest that the body is retaining fluid.
For example, a patient who suddenly gains weight over several days while also developing swelling or breathlessness may be experiencing worsening congestion.
Daily weight remains a useful part of heart failure self-management.
But it has limitations.
Not every change in cardiovascular pressure immediately produces noticeable weight gain.
Weight also changes for many reasons unrelated to worsening heart failure:
food intake,
bowel movements,
clothing,
hydration,
different weighing times, or
differences between scales.
A patient may therefore begin deteriorating before the scale clearly reflects it.
The European Society of Cardiology consensus statement notes that clinical signs, including body weight, have relatively poor sensitivity for identifying congestion at its earliest stage. (onlinelibrary.wiley.com)
This does not mean patients should stop weighing themselves.
It means that one measurement alone cannot tell the whole story.
Nurses Already Look for Patterns, Not Just One Number
Heart failure nursing has always involved surveillance.
A nurse does not usually look at one finding and immediately make a conclusion.
Instead, several pieces of information are considered together.
A nurse might notice:
Weight increased by 1.5 kilograms.
But then ask:
Is the patient more breathless?
Are the ankles swollen?
Has urine output changed?
Is blood pressure different?
Has heart rate increased?
Has the patient been eating more salty food?
Did the patient miss a diuretic dose?
Is the patient taking a medication that could contribute to fluid retention?
Has there been an infection?
Is there a new arrhythmia?
This is important because worsening heart failure often develops as a pattern of changes rather than one isolated abnormality.
Remote monitoring expands the number of patterns healthcare teams may be able to see.
What Is Pulmonary Artery Pressure Monitoring?
One of the most interesting developments in heart failure monitoring is the use of an implantable sensor that measures pressure in the pulmonary artery.
The pulmonary artery carries blood from the right side of the heart toward the lungs.
Changes in pressure within this circulation can provide information about the patient's hemodynamic status.
One commercially available system is CardioMEMS.
A small wireless pressure sensor is implanted into a branch of the pulmonary artery through a catheter-based procedure.
Once the patient returns home, readings can be collected regularly and transmitted remotely to the heart failure team.
There is no battery inside the implanted sensor.
Instead, the patient uses external equipment to obtain and transmit measurements.
Healthcare professionals can then review pressure trends without waiting for the patient to attend a clinic appointment.
NICE describes the goal of this approach as identifying changes in pulmonary artery pressure that can guide ongoing heart failure management and help reduce heart-failure-related hospitalization.
Why Is Pulmonary Artery Pressure Different From Checking Symptoms?
Imagine two stages of heart failure deterioration.
Stage One: The Pressure Is Rising
Pulmonary artery pressure begins increasing.
The patient may still say:
“I feel fine.”
There may be no obvious ankle swelling.
Body weight may have changed very little.
The patient is still completing normal activities.
Stage Two: Congestion Becomes Obvious
Several days later, the patient begins experiencing:
breathlessness,
edema,
reduced exercise tolerance,
weight gain, or
difficulty sleeping flat.
Now deterioration is much easier to recognize.
The advantage of pulmonary artery pressure monitoring is that healthcare professionals may be able to intervene during the first stage rather than waiting for the second.
The 2025 Heart Failure Association consensus statement notes that pulmonary artery pressure can increase several days before overt congestion develops, allowing therapy to potentially be adjusted earlier.
This changes heart failure care from being primarily reactive toward becoming more proactive.
Instead of waiting for the patient to say:
“I can't breathe properly anymore,”
the healthcare team may see:
“Your pressures have been rising for several days. Let's find out why.”
What Happens When the Pressure Starts Rising?
A higher pulmonary artery pressure reading does not automatically mean the patient needs to go to hospital.
First, the team needs to understand the trend.
The European Society of Cardiology consensus recommends looking at pressure changes over several days rather than reacting to every isolated value.
When meaningful increases occur, healthcare teams may contact the patient to investigate possible causes.
Questions might include:
Have you developed new shortness of breath?
Are your legs more swollen?
Has your weight changed?
Have you missed any medications?
Have you eaten unusually salty foods?
Are you drinking more fluid than recommended?
Have you developed fever or infection?
Are you experiencing palpitations?
Have you started any new medication?
Depending on the situation, treatment may then be adjusted.
For example, clinicians may modify diuretic therapy or other heart failure medications when clinically appropriate.
If the patient's symptoms or physiological changes suggest more serious deterioration, an in-person assessment or emergency evaluation may be necessary.
The monitor therefore does not make the treatment decision.
It provides an earlier opportunity to ask the right questions.
This Is Where Nurses Become Essential
A sensor can transmit thousands of measurements.
But a sensor cannot call the patient.
It cannot ask whether the patient forgot medication.
It cannot hear that the patient sounds unusually breathless on the telephone.
It cannot determine whether new dizziness began after a medication change.
And it cannot educate the patient about reducing sodium intake or following an agreed fluid plan.
That is why remote heart failure monitoring requires a clinical team around the technology.
A June 2026 real-world study provides an especially interesting example.
Researchers evaluated six years of nursing-led CardioMEMS monitoring in a specialized heart failure unit.
The study included 75 patients, with an average age of approximately 73 years.
During follow-up, nurses performed 2,853 interventions.
The most common reason for intervention was a change in pulmonary artery pressure, accounting for 64% of intervention triggers.
Nursing-led actions included:
telephone contact with patients,
treatment adjustments within the clinical pathway,
visits to the heart failure unit,
advice related to fluid restriction, and
referral to emergency services when necessary.
More than half of the interventions involved telephone communication with patients.
The study illustrates an important point:
The value of remote monitoring does not come from the sensor alone.
It comes from what the healthcare team does with the information.
One Rising Number Can Lead to an Entire Nursing Assessment
Suppose a nurse reviewing remote data sees that pulmonary artery pressure has increased for three consecutive days.
The patient has not called the clinic.
There is no emergency department visit.
There is no obvious crisis yet.
The nurse contacts the patient.
During the conversation, the patient says:
“I feel okay, maybe just a little more tired.”
The nurse asks about weight.
It has increased slightly.
Then medication.
The patient admits missing several doses of a diuretic because they were away from home.
The patient has also eaten restaurant meals for several days.
Now the pressure trend has context.
Following the heart failure team's protocol, the patient's treatment plan can be reviewed and follow-up arranged.
This is the potential advantage of remote monitoring:
intervention may happen while the problem is still relatively small.
Can This Actually Reduce Hospitalizations?
Evidence increasingly suggests that pulmonary artery pressure-guided management can reduce heart failure hospitalizations in appropriately selected patients.
The Heart Failure Association consensus reviewed randomized clinical trials showing reductions in heart-failure-related hospitalization with pulmonary artery pressure-guided therapy across patients with different levels of left ventricular ejection fraction.
A 2026 international post-market study also evaluated CardioMEMS use outside the United States.
The registry included 304 patients from 37 centers across six countries with NYHA class III heart failure and a recent history of heart failure hospitalization.
The sensor was successfully implanted in 98.3% of participants, and the study evaluated both long-term device safety and changes in hospitalization after implantation.
This growing evidence influenced healthcare policy as well.
In February 2026, the United Kingdom's National Institute for Health and Care Excellence, or NICE, recommended CardioMEMS as an option for remote monitoring in selected adults with NYHA class III chronic heart failure who are at risk of hospitalization, provided they are able to use the technology and willing to adjust medication as directed.
That is an important development.
Remote pulmonary artery monitoring is no longer simply an experimental idea.
For selected patients, it is becoming part of routine heart failure management.
But CardioMEMS Is Not for Everyone
This is equally important.
Remote pulmonary artery pressure monitoring should not be interpreted as something every person with heart failure needs.
Patient selection matters.
NICE's 2026 recommendation specifically applies to selected adults with NYHA class III chronic heart failure who are at risk of hospitalization and can participate appropriately in the monitoring and treatment process.
Patients need to transmit their measurements consistently.
They need access to a healthcare team capable of reviewing the data.
They need to understand what the technology does and does not do.
Most importantly, clinicians need a structured system for responding to abnormal results.
A sensor without clinical follow-up is simply a source of data.
Remote Monitoring Is More Than CardioMEMS
Implantable pulmonary artery sensors are only one part of the rapidly developing world of heart failure telemonitoring.
Other approaches may combine information such as:
body weight,
blood pressure,
heart rate,
oxygen saturation,
physical activity,
heart rhythm,
symptom questionnaires, and
data from cardiac implantable electronic devices.
Some systems are wearable.
Some rely on equipment the patient uses each day.
Others use implanted cardiovascular devices.
Future systems may combine several of these signals and use algorithms to determine which patients are becoming unstable.
However, not every form of remote monitoring has produced the same clinical benefit.
Collecting more data does not automatically prevent hospitalization.
The information needs to be reliable, clinically meaningful, and connected to an effective care pathway.
Patients Still Need to Know Their Own Warning Signs
Advanced monitoring does not make self-care less important.
Even patients using sophisticated remote technology should understand common signs of worsening heart failure.
Patients should contact their healthcare team according to their individual care plan when they develop changes such as:
increasing shortness of breath,
worsening swelling,
rapid or unexpected weight gain,
increasing fatigue,
reduced ability to perform usual activities,
needing more pillows to breathe comfortably while sleeping,
waking suddenly because of breathlessness,
persistent cough,
dizziness, or
changes in heart rate or rhythm.
Severe breathlessness at rest, fainting, chest pain, confusion, blue or gray discoloration, or other signs of serious deterioration may require urgent medical attention.
Remote monitoring should therefore complement patient education rather than replace it.
The Most Powerful Tool May Still Be a Phone Call
It sounds almost surprisingly simple.
An implanted sensor may use sophisticated biomedical engineering to measure pressure from inside the pulmonary artery.
The information travels digitally to a clinical platform.
Algorithms display trends.
Healthcare professionals review the data.
And then one of the most useful interventions may be:
a nurse calling the patient.
That phone call may uncover a missed medication.
A new infection.
A change in diet.
An arrhythmia.
Increasing breathlessness.
Dizziness after medication adjustment.
Or simply confusion about the treatment plan.
Technology detects the signal.
Communication gives the signal meaning.
Could This Change the Meaning of “Stable Heart Failure”?
Traditionally, a patient may appear stable because:
there is no shortness of breath,
there is no edema,
weight is unchanged, and
the patient has not contacted the hospital.
But remote hemodynamic monitoring introduces another possibility.
A patient can feel clinically stable while physiological deterioration is beginning underneath the surface.
This means heart failure care may increasingly move away from asking only:
“How do you feel today?”
toward also asking:
“What has been changing inside your cardiovascular system over the last several days?”
Both questions matter.
One describes the patient's experience.
The other may help reveal what could happen next.
Nurses Are Moving From Reactive Care Toward Predictive Care
This may be one of the most interesting nursing implications.
Traditional acute care often responds after symptoms become obvious.
A patient develops severe breathlessness.
The patient calls an ambulance.
The emergency department treats pulmonary congestion.
The patient is admitted.
Remote monitoring creates the possibility of an earlier pathway:
Pressure begins rising.
The nursing team notices the trend.
The nurse contacts the patient.
Potential triggers are identified.
The multidisciplinary team adjusts management.
Pressure returns toward the patient's target range.
Hospitalization may potentially be avoided.
That shift from responding to deterioration toward recognizing risk before overt deterioration may become an increasingly important part of chronic-disease nursing.
But it requires more than new devices.
It requires nurses trained in:
interpreting trends,
remote assessment,
patient communication,
heart failure self-management,
medication monitoring,
escalation protocols, and
digital health technology.
The European Society of Cardiology consensus specifically emphasizes that pulmonary artery pressure monitoring programs require trained healthcare personnel, including dedicated nurses or technicians, who can interpret data and coordinate timely intervention.
The Bottom Line
Heart failure deterioration may begin before the patient realizes something is wrong.
By the time visible swelling, rapid weight gain, or severe breathlessness develops, cardiovascular pressures may already have been rising for several days.
Traditional self-monitoring remains valuable.
Daily weight, symptoms, blood pressure, medication adherence, activity tolerance, and edema still provide important information.
But implantable pulmonary artery pressure sensors are adding another layer of surveillance.
For selected patients, remote monitoring can allow heart failure teams to identify hemodynamic changes earlier and potentially adjust treatment before obvious decompensation develops.
The latest evidence also makes one thing particularly clear:
the technology does not work alone.
Behind every transmitted pressure reading needs to be a clinical system capable of interpreting it.
And in many heart failure programs, nurses are at the center of that system.
A sensor may be able to detect that pressure is rising.
But it takes a healthcare professional to ask:
Why is it rising?
What has changed?
What does this patient need today?
And perhaps most importantly:
Can we intervene now, before this patient becomes sick enough to need a hospital bed?
References
Gonzalez Fernandez, B., et al. (2026). Nursing-Led Remote Monitoring With CardioMEMS in Heart Failure: Impact on Clinical Stability and Hospitalisations in a Six-Year Real-World Experience. European Journal of Heart Failure, 28(Suppl 2).
de Groote, P., et al. (2026). Heart Failure Hospitalization Reduction and Long-Term Safety With Remote Pulmonary Artery Pressure Monitoring: Results of the CardioMEMS Heart Failure System Outside United States Post-Market Study. European Heart Journal Open, 6(2).
Bayes-Genis, A., et al. (2025). Remote Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure: A Clinical Consensus Statement of the Heart Failure Association of the ESC. European Journal of Heart Failure, 27(9), 1644–1657.
National Institute for Health and Care Excellence. (2026). Pulmonary Artery Pressure Technologies for Remote Monitoring of Chronic Heart Failure. HealthTech Guidance HTG769.
Heidenreich, P. A., et al. (2022). AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation.
Tidak ada komentar:
Posting Komentar